AGREEMENT AND PLAN OF MERGERMerger Agreement • April 13th, 2022 • Antares Pharma, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledApril 13th, 2022 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER is made and entered into as of April 12, 2022, by and among Halozyme Therapeutics, Inc., a Delaware corporation (“Parent”), Atlas Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”), and Antares Pharma, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
AGREEMENT AND PLAN OF MERGERMerger Agreement • April 13th, 2022 • Antares Pharma, Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledApril 13th, 2022 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER is made and entered into as of April 12, 2022, by and among Halozyme Therapeutics, Inc., a Delaware corporation (“Parent”), Atlas Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”), and Antares Pharma, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.